米国の医療ツーリズム市場規模、シェア、動向分析レポート：タイプ別、消費者行動別、主要企業別、競合分析、セグメント予測、2025年～203年

米国の医療ツーリズム市場規模と動向：

米国の医療ツーリズム市場規模は2024年に87億4,000万米ドルと推定され、予測期間中にCAGR 13.20%で成長し、2033年には265億8,000万米ドルに達すると予測されます。

同市場は、国際的に認定された病院の存在感が高まり、最先端の治療を提供することで高い評価を得ていることを背景に、近年大きな成長を遂げています。米国のヘルスケア施設では、患者中心の個別ケアを重視する傾向が強まっており、同国の医療ツーリズム産業を大きく牽引しています。

病院や診療所では、患者一人ひとりのニーズに合わせた治療、個別化されたケアプランの提供、全体的な患者体験の向上にますます力を入れるようになっています。このような質の高い患者中心の医療は、健康への高度でカスタマイズされたアプローチを求める外国人患者から高い需要が見込まれます。

米国には国際的に認定された病院が存在することが、インバウンド医療ツーリズムの成長を後押ししています。世界の患者がヘルスケアの決定において安全性、品質、透明性をますます優先するようになる中、米国は厳しい国際基準を満たす施設を提供することで、好ましい目的地としての地位を確立しています。米国国際患者プログラム協同組合（USCIPP）の2023年の報告書によると、米国の60の組織が47,002人の外国人患者を支援し、1会計年度で合計21億米ドルの総収入を計上しました。さらに、ジョイント・コミッション・インターナショナル（JCI）、世界・ヘルスケア・アクレディテーション（GHA）、DNV-GLといった世界的に認知された組織から認定を受けた病院は、競争の激しい医療ツーリズムの中で際立っており、医療の質や手続きの完全性に関して患者に安心感を与えています。

さらに、国際的な訓練を受けた医師の存在は、米国のインバウンド医療ツーリズム産業の成長を支える重要な役割を果たしています。このような医師は、一般に国際医学部卒業生（IMG）と呼ばれ、国内の医療労働力のかなりの部分を占めています。The Hospitalistによると、2023年には米国で活躍する医師の約25％がIMGです。これらの医師は、インド、パキスタン、ナイジェリアなど、さまざまな国の出身で、多様な臨床専門知識と多言語能力を備えています。このような資質は、臨床労働力を強化し、文化的に敏感な医療環境を育むものであり、個別化された身近な医療体験を求める外国人患者にとって特に貴重なものです。

さらに、米国から医療ツーリズムに出かける主な原動力の一つは、国内の医療費が非常に高いことです。メディケア＆メディケイド・サービスセンター（CMS）によると、米国の国民医療費は2022年に4兆5,000億米ドルに達し、1人当たり平均約13,493米ドル、GDPの約17.3％を占めます。この数字は、米国におけるヘルスケアの経済的負担の大きさを物語っています。

一方、米国国勢調査局によると、2023年時点でも米国人口の約8％が無保険であり、92％が保険に加入しています。保険に加入している人でさえ、高額な免責金額、自己負担金、または共同保険にしばしば遭遇し、多くの重要な治療が経済的に手が届かなくなっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国への医療観光：市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 補助市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• ビジネス環境分析ツール
  • ポーターのファイブフォース分析
  • PESTLE分析

第4章 米国インバウンド医療ツーリズム市場分析

• 米国インバウンド医療観光市場の推定と予測、2018年から2030年
  • 規制と償還シナリオ
  • 2024年のインバウンド治療/処置分析（処置の種類）
  • 2024年の入院患者分析（％）（患者由来）
  • 2018年～2030年の入院患者数分析（患者数）
  • 患者1人あたりの平均支出、2024年

第5章 競合分析

• 企業分類
• 企業の市況分析
• 戦略マッピング
• 企業プロファイル/上場企業
  • Cleveland Clinic
  • Mayo Clinic
  • The Johns Hopkins Hospital
  • Cedars-Sinai
  • Massachusetts General Hospital
  • UCSF Health
  • NewYork-Presbyterian Hospital
  • Ronald Reagan UCLA Medical Center
  • Northwestern Memorial Hospital
  • Stanford Health Care

第6章 米国のアウトバウンド医療ツーリズム：市場の変数、動向、範囲

• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• ビジネス環境分析ツール
  • ポーターのファイブフォース分析
  • PESTLE分析

第7章 米国のアウトバウンド医療観光市場分析

• 米国アウトバウンド医療ツーリズム市場の推定と予測、2018年から2030年
• 国別、2018年から2030年
  • メキシコ
  • カナダ
  • インド
  • コスタリカ
  • タイ
  • ブラジル
  • その他の国
  • 2024年の外来治療・処置分析（処置の種類）
  • 2018年～2030年の外来患者数分析（患者数）

第8章 米国のアウトバウンド医療観光市場：保険適用範囲

• アウトバウンド医療ツーリズムのメディケア適用範囲：定性分析

第9章 米国のアウトバウンド医療観光市場：戦略的枠組み

• 戦略的取り組み
• 海外医療ツーリズムを促進するパートナーシップとコラボレーション
• 米国の患者を惹きつける米国外の主要国際病院

List of Tables

• TABLE 1 List of secondary sources
• TABLE 2 List of abbreviations
• TABLE 3 Average cardiovascular treatment price range comparison
• TABLE 4 U.S. inbound patient traffic analysis, 2018 - 2030
• TABLE 5 Approximate medical procedure cost comparison between the mentioned destinations (USD)
• TABLE 6 Global JCI-accredited hospitals
• TABLE 7 Savings comparison on medical procedures and travel times
• TABLE 8 Average bariatric treatment price range comparison
• TABLE 9 Average orthopedic treatment price range comparison
• TABLE 10 Average cosmetic treatment price range comparison
• TABLE 11 Average orthopedic treatment price range comparison with India
• TABLE 12 Average orthopedic treatment price range comparison with Costa Rica
• TABLE 13 U.S. average ophthalmology treatment price range comparison with Thailand
• TABLE 14 U.S. average cosmetic treatment price range comparison with Brazil
• TABLE 15 U.S. outbound patient traffic analysis, 2018 - 2030
• TABLE 16 Leading non-U.S. based international hospitals

List of Figures

• FIG. 1 Market segmentation
• FIG. 2 Market research process
• FIG. 3 Data triangulation techniques
• FIG. 4 Primary research pattern
• FIG. 5 Market research approaches
• FIG. 6 Value chain-based sizing & forecasting
• FIG. 7 Market formulation & validation
• FIG. 8 Market snapshot
• FIG. 9 Market segmentation
• FIG. 10 Competitive landscape
• FIG. 11 U.S. inbound medical tourism market dynamics
• FIG. 12 Market driver relevance analysis (Current & future impact)
• FIG. 13 Market restraint relevance analysis (Current & future impact)
• FIG. 14 U.S. inbound medical tourism market: Porter's five forces analysis
• FIG. 15 U.S. inbound medical tourism market: PESTLE analysis
• FIG. 16 U.S. inbound medical tourism market estimates & forecasts, 2018 to 2030 (USD Million)
• FIG. 17 U.S. inbound treatments/procedures analysis, 2024 (Type of procedures)
• FIG. 18 U.S. inbound patient analysis, 2024 (%) (Patient origin)
• FIG. 19 Company/competition categorization
• FIG. 20 Company market position analysis
• FIG. 21 Strategy mapping
• FIG. 22 U.S. outbound medical tourism market dynamics
• FIG. 23 Market driver relevance analysis (Current & future impact)
• FIG. 24 Market restraint relevance analysis (Current & future impact)
• FIG. 25 U.S. outbound medical tourism market: Porter's five forces analysis
• FIG. 26 U.S. outbound medical tourism market: PESTLE analysis
• FIG. 27 U.S. outbound medical tourism market, 2018 - 2030 (USD Million)
• FIG. 28 Mexico market, 2018 - 2030 (USD Million)
• FIG. 29 Canada market, 2018 - 2030 (USD Million)
• FIG. 30 India market, 2018 - 2030 (USD Million)
• FIG. 31 Costa Rica market, 2018 - 2030 (USD Million)
• FIG. 32 Thailand market, 2018 - 2030 (USD Million)
• FIG. 33 Brazil market, 2018 - 2030 (USD Million)
• FIG. 34 Rest of World market, 2018 - 2030 (USD Million)
• FIG. 35 U.S. outbound treatments/procedures analysis, 2024 (Type of procedures)

U.S. Medical Tourism Market Size & Trends:

The U.S. medical tourism market size was estimated at USD 8.74 billion in 2024 and is projected to grow at a CAGR of 13.20% over the forecast period to reach an estimated value of USD 26.58 billion by 2033. The market has experienced significant growth in recent times, driven by the increasing presence of internationally accredited hospitals and the reputation for providing cutting-edge medical treatments. The growing emphasis on personalized and patient-centric care in U.S. healthcare facilities is significantly driving the medical tourism industry in the country.

Hospitals and clinics increasingly focus on tailored treatments to individual patient needs, providing personalized care plans, and enhancing the overall patient experience. This high-quality, patient-centered care is expected to witness high demand from international patients seeking an advanced and customized approach to their health.

The presence of internationally accredited hospitals in the U.S. is driving the growth of the inbound medical tourism. As global patients increasingly prioritize safety, quality, and transparency in their healthcare decisions, the U.S. has positioned itself as a preferred destination by offering facilities that meet stringent international standards. As per the 2023 report by The U.S. Cooperative for International Patient Programs (USCIPP), 60 different U.S. organizations assisted 47,002 international patients and reported gross revenue charges totaling USD 2.1 billion in a single fiscal year. Furthermore, hospitals accredited by globally recognized organizations such as Joint Commission International (JCI), Global Healthcare Accreditation (GHA), and DNV-GL stand out in a competitive medical tourism landscape, offering reassurance to patients regarding care quality and procedural integrity.

Moreover, the presence of internationally trained physicians plays a significant role in supporting the growth of the U.S. inbound medical tourism industry. These physicians, commonly referred to as International Medical Graduates (IMGs), comprise a substantial portion of the national medical workforce. According to The Hospitalist, in 2023, nearly 25 percent of active physicians in the U.S. were IMGs. These physicians originate from a wide range of countries, including India, Pakistan, and Nigeria, and bring with them diverse clinical expertise and multilingual capabilities. These qualities strengthen the clinical workforce and foster a culturally sensitive care environment that is especially valuable for international patients seeking personalized and familiar care experiences.

Furthermore, one of the primary drivers of outbound medical tourism from the U.S. is the exceptionally high cost of healthcare domestically. According to the Centers for Medicare & Medicaid Services (CMS), U.S. national health expenditures reached USD 4.5 trillion in 2022, averaging approximately USD 13,493 per person, accounting for about 17.3 percent of GDP. These figures underscore the steep financial burden of healthcare in the U.S.

Meanwhile, the U.S. Census Bureau reports that roughly 8 percent of the U.S. population remained uninsured in 2023, with a similar proportion, 92 percent, insured at some point during the year. Even those who are insured often encounter high deductibles, copayments, or coinsurance, making many vital treatments financially inaccessible.

U.S. Medical Tourism Market Report Segmentation

This report forecasts revenue growth, country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. medical tourism market report based on type.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Inbound Medical Tourism
• Outbound Medical Tourism

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates and Forecast Timeline
• 1.2 Research Methodology
  • 1.2.1 Information procurement
    • 1.2.1.1 Purchased database
  • 1.2.2 GVR's internal database
    • 1.2.2.1 Secondary sources
    • 1.2.2.2 Primary research
• 1.3 Information or Data Analysis
  • 1.3.1 Data Analysis Models
• 1.4 Market Formulation & Validation
• 1.5 Model Details
  • 1.5.1 Bottom Up Approach
    • 1.5.1.1 Market Estimation Framework
      • 1.5.1.1.1. Pillar I - Secondary Research
      • 1.5.1.1.2. Pillar II - Primary Research
      • 1.5.1.1.3. Pillar III - Internal Benchmarking and Modeling
    • 1.5.1.2 Segmented Estimation Approach
      • 1.5.1.2.1. Inbound Medical Tourism Estimation
      • 1.5.1.2.2. Outbound Medical Tourism Estimation
    • 1.5.1.3 Forecasting Methodology (2025 - 2030)
• 1.6 List of Secondary Sources
• 1.7 List of Abbreviations
• 1.8 Objectives
  • 1.8.1 Objective - 1
  • 1.8.2 Objective - 2
  • 1.8.3 Objective - 3

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Market Segmentation
• 2.3 Competitive Landscape

Chapter 3 U.S. Inbound Medical Tourism: Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Presence of International Accreditation Hospitals
      • 3.2.1.1.1. Case Study: Impact of Hospital Accreditation on Medicare Patient Outcomes in the U.S.
    • 3.2.1.2 Presence of internationally trained physicians
      • 3.2.1.2.1. Case Study: Comparative Patient Outcomes Between U.S.-Trained and Foreign-Trained Physicians
    • 3.2.1.3 Access to Advanced Medical Technology and Treatments
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 High Cost of Procedures
    • 3.2.2.2 Follow-Up Problems
  • 3.2.3 Market Opportunity Analysis
    • 3.2.3.1 Partnerships with International Insurers and Governments
  • 3.2.4 Market Challenges Analysis
    • 3.2.4.1 Visa and Immigration Barriers
• 3.3 Business Environment Analysis Tools
  • 3.3.1 Porter's Five Forces Analysis
  • 3.3.2 PESTLE Analysis

Chapter 4 U.S. Inbound Medical Tourism Market Analysis

• 4.1 U.S. Inbound Medical Tourism Market Estimates & Forecasts, 2018 to 2030 (USD Million)
  • 4.1.1 Regulatory & Reimbursement Scenario
    • 4.1.1.1 Regulatory Framework
    • 4.1.1.2 Reimbursement Scenario
  • 4.1.2 Inbound Treatments/Procedures Analysis, 2024 (Type of Procedures)
  • 4.1.3 Inbound Patient Analysis, 2024 (%) (Patient Origin)
  • 4.1.4 Inbound Patient Traffic Analysis, 2018 - 2030 (Number of Patients)
  • 4.1.5 Average Spend Per Patient, 2024

Chapter 5 Competitive Analysis

• 5.1. Company Categorization
• 5.2. Company Market Position Analysis
• 5.3. Strategy Mapping
• 5.4. Company Profiles/Listing
  • 5.1.1. Cleveland Clinic
    • 5.1.1.1. Overview
    • 5.1.1.2. Financial Performance
    • 5.1.1.3. Service Benchmarking
    • 5.1.1.4. Strategic Initiatives
  • 5.1.2. Mayo Clinic
    • 5.1.2.1. Overview
    • 5.1.2.2. Financial Performance
    • 5.1.2.3. Service Benchmarking
    • 5.1.2.4. Strategic Initiatives
  • 5.1.3. The Johns Hopkins Hospital
    • 5.1.3.1. Overview
    • 5.1.3.2. Financial Performance
    • 5.1.3.3. Service Benchmarking
    • 5.1.3.4. Strategic Initiatives
  • 5.1.4. Cedars-Sinai
    • 5.1.4.1. Overview
    • 5.1.4.2. Financial Performance
    • 5.1.4.3. Service Benchmarking
    • 5.1.4.4. Strategic Initiatives
  • 5.1.5. Massachusetts General Hospital
    • 5.1.5.1. Overview
    • 5.1.5.2. Financial Performance
    • 5.1.5.3. Service Benchmarking
    • 5.1.5.4. Strategic Initiatives
  • 5.1.6. UCSF Health
    • 5.1.6.1. Overview
    • 5.1.6.2. Financial Performance
    • 5.1.6.3. Service Benchmarking
    • 5.1.6.4. Strategic Initiatives
  • 5.1.7. NewYork-Presbyterian Hospital
    • 5.1.7.1. Overview
    • 5.1.7.2. Financial Performance
    • 5.1.7.3. Service Benchmarking
    • 5.1.7.4. Strategic Initiatives
  • 5.1.8. Ronald Reagan UCLA Medical Center
    • 5.1.8.1. Overview
    • 5.1.8.2. Financial Performance
    • 5.1.8.3. Service Benchmarking
    • 5.1.8.4. Strategic Initiatives
  • 5.1.9. Northwestern Memorial Hospital
    • 5.1.9.1. Overview
    • 5.1.9.2. Financial Performance
    • 5.1.9.3. Service Benchmarking
    • 5.1.9.4. Strategic Initiatives
  • 5.1.10. Stanford Health Care
    • 5.1.10.1. Overview
    • 5.1.10.2. Financial Performance
    • 5.1.10.3. Service Benchmarking
    • 5.1.10.4. Strategic Initiatives

Chapter 6 U.S. Outbound Medical Tourism: Market Variables, Trends & Scope

• 6.1 Market Dynamics
  • 6.1.1 Market Driver Analysis
    • 6.1.1.1 High Cost of Medical Treatments
    • 6.1.1.2 Longer Waiting Time
    • 6.1.1.3 Limited Insurance Coverage for Some Procedures
  • 6.1.2 Market Restraint Analysis
    • 6.1.2.1 Medical Risks Associated with Medical Tourism
    • 6.1.2.2 Follow-Up Problems
  • 6.1.3 Market Opportunity Analysis
    • 6.1.3.1 Improved Quality and Infrastructure in Destination Countries
  • 6.1.4 Market Challenges Analysis
    • 6.1.4.1 Limited Legal Recourse and Liability Protection
• 6.2 Business Environment Analysis Tools
  • 6.2.1 Porter's Five Forces Analysis
  • 6.2.2 PESTLE Analysis

Chapter 7 U.S. Outbound Medical Tourism Market Analysis

• 7.1 U.S. Outbound Medical Tourism Market Estimates & Forecasts, 2018 to 2030 (USD Million)
  • 7.1.1.1 U.S. Outbound Medical Tourism market, 2018 - 2030 (USD Million)
• 7.2 U.S. Outbound Medical Tourism Market Estimates & Forecasts, by Country, 2018 to 2030 (USD Million)
  • 7.2.1 Mexico
    • 7.2.1.1 Mexico Market, 2018 - 2030 (USD Million)
  • 7.2.2 Canada
    • 7.2.2.1 Canada Market, 2018 - 2030 (USD Million)
  • 7.2.3 India
    • 7.2.3.1 India Market, 2018 - 2030 (USD Million)
  • 7.2.4 Costa Rica
    • 7.2.4.1 Costa Rica Market, 2018 - 2030 (USD Million)
  • 7.2.5 Thailand
    • 7.2.5.1 Thailand Market, 2018 - 2030 (USD Million)
  • 7.2.6 Brazil
    • 7.2.6.1 Brazil Market, 2018 - 2030 (USD Million)
  • 7.2.7 Rest of World
    • 7.2.7.1 Rest of World Market, 2018 - 2030 (USD Million)
  • 7.2.8 Outbound Treatments/Procedures Analysis, 2024 (Type of Procedures)
  • 7.2.9 Outbound Patient Traffic Analysis, 2018 - 2030 (Number of Patients)

Chapter 8 U.S. Outbound Medical Tourism Market: Insurance Coverage

• 8.1 Medicare Coverage for Outbound Medical Tourism: Qualitative Analysis
  • 8.1.1 Medicare Coverage for Healthcare Services in Foreign Hospitals
  • 8.1.2 Services Covered by Medicare
  • 8.1.3 Services Not Covered by Medicare
  • 8.1.4 Medicare Supplement Insurance (Medigap)
  • 8.1.5 Medicare Health Plans Other Than Original Medicare

Chapter 9 U.S. Outbound Medical Tourism Market: Strategic Framework

• 9.1 Strategic Initiatives
• 9.2 Partnerships & Collaborations Encouraging Outbound Medical Tourism
• 9.3 Leading Non-U.S. Based International Hospitals Attracting U.S. Patients